InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Kadlec Robert Peter. Director active across 1 company, notably MiNK Therapeutics, Inc.. Aggregated, 5 reports have been published. Activity tracked since 1 December 2024. The latest transaction was filed on 1 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Kadlec Robert Peter is an insider and appears in 5 filings in total. In the sampled recent filings we hold, all relating to MiNK Therapeutics, Inc., the reported amounts are linked to attribution transactions, with a date range from 2024-12-09 to 2025-12-03 and individual amounts of EUR 12964.89187848396, EUR 11787.81830292832, EUR 11643.02862181779, EUR 11613.50112969913 and EUR 8490.743671941005.